Novo Nordisk to Boost Wegovy Production in France
Wall Street Journal
Novo Nordisk said it will invest more than $2 billion in its French production site as it seeks to meet rising demand for its blockbuster obesity and diabetes treatments.
Wall Street Journal
Novo Nordisk said it will invest more than $2 billion in its French production site as it seeks to meet rising demand for its blockbuster obesity and diabetes treatments.